Búsqueda | Portal de Búsqueda de la BVS

1.

Phase 1/2 study of uproleselan added to chemotherapy in patients with relapsed or refractory acute myeloid leukemia.

DeAngelo, Daniel J; Jonas, Brian A; Liesveld, Jane L; Bixby, Dale L; Advani, Anjali S; Marlton, Paula; Magnani, John L; Thackray, Helen M; Feldman, Eric J; O'Dwyer, Michael E; Becker, Pamela S.

Blood ; 139(8): 1135-1146, 2022 02 24.

Artículo en Inglés | MEDLINE | ID: mdl-34543383

2.

Concurrent transposon engineering and CRISPR/Cas9 genome editing of primary CLL-1 chimeric antigen receptor-natural killer cells.

Gurney, Mark; O'Reilly, Eimear; Corcoran, Sarah; Brophy, Sarah; Krawczyk, Janusz; Otto, Neil M; Hermanson, David L; Childs, Richard W; Szegezdi, Eva; O'Dwyer, Michael E.

Cytotherapy ; 24(11): 1087-1094, 2022 11.

Artículo en Inglés | MEDLINE | ID: mdl-36050244

3.

Phase 2 studies of lenalidomide, subcutaneous bortezomib, and dexamethasone as induction therapy in patients with newly diagnosed multiple myeloma.

O'Gorman, Peter; Laubach, Jacob P; O'Dwyer, Michael E; Krawczyk, Janusz; Yee, Andrew J; Gilligan, Oonagh; Cahill, Mary R; Rosenblatt, Jacalyn; Quinn, John; Murphy, Philip T; DiPietro, Heidi; Perera, Meegahage Ratnakanthi; Crotty, Gerard M; Cummings, Kristen; Hayden, Patrick J; Browne, Paul; Savell, Alexandra; O'Leary, Hilary M; O'Keeffe, Denis; Masone, Kelly; Hennessy, Brian J; Guerrero Garcia, Thomas; Scott, Kathleen; Saeed, Khalid; Bianchi, Giada; Dowling, Paul; Tierney, Ciara; Richardson, Paul G.

Am J Hematol ; 97(5): 562-573, 2022 05.

Artículo en Inglés | MEDLINE | ID: mdl-35132679

4.

European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when.

Caers, Jo; Garderet, Laurent; Kortüm, K Martin; O'Dwyer, Michael E; van de Donk, Niels W C J; Binder, Mascha; Dold, Sandra Maria; Gay, Francesca; Corre, Jill; Beguin, Yves; Ludwig, Heinz; Larocca, Alessandra; Driessen, Christoph; Dimopoulos, Meletios A; Boccadoro, Mario; Gramatzki, Martin; Zweegman, Sonja; Einsele, Hermann; Cavo, Michele; Goldschmidt, Hartmut; Sonneveld, Pieter; Delforge, Michel; Auner, Holger W; Terpos, Evangelos; Engelhardt, Monika.

Haematologica ; 103(11): 1772-1784, 2018 11.

Artículo en Inglés | MEDLINE | ID: mdl-30171031

5.

The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma.

Glavey, Siobhan V; Manier, Salomon; Natoni, Alessandro; Sacco, Antonio; Moschetta, Michele; Reagan, Michaela R; Murillo, Laura S; Sahin, Ilyas; Wu, Ping; Mishima, Yuji; Zhang, Yu; Zhang, Wenjing; Zhang, Yong; Morgan, Gareth; Joshi, Lokesh; Roccaro, Aldo M; Ghobrial, Irene M; O'Dwyer, Michael E.

Blood ; 124(11): 1765-76, 2014 Sep 11.

Artículo en Inglés | MEDLINE | ID: mdl-25061176

6.

Targeting stromal cell sialylation reverses T cell-mediated immunosuppression in the tumor microenvironment.

Egan, Hannah; Treacy, Oliver; Lynch, Kevin; Leonard, Niamh A; O'Malley, Grace; Reidy, Eileen; O'Neill, Aoise; Corry, Shania M; De Veirman, Kim; Vanderkerken, Karin; Egan, Laurence J; Ritter, Thomas; Hogan, Aisling M; Redmond, Keara; Peng, Li; Che, Jenny; Gatlin, Wayne; Jayaraman, Pushpa; Sheehan, Margaret; Canney, Aoife; Hynes, Sean O; Kerr, Emma M; Dunne, Philip D; O'Dwyer, Michael E; Ryan, Aideen E.

Cell Rep ; 42(5): 112475, 2023 05 30.

Artículo en Inglés | MEDLINE | ID: mdl-37167967

7.

Targeting hypersialylation in multiple myeloma represents a novel approach to enhance NK cell-mediated tumor responses.

Daly, John; Sarkar, Subhashis; Natoni, Alessandro; Stark, Jessica C; Riley, Nicholas M; Bertozzi, Carolyn R; Carlsten, Mattias; O'Dwyer, Michael E.

Blood Adv ; 6(11): 3352-3366, 2022 06 14.

Artículo en Inglés | MEDLINE | ID: mdl-35294519

8.

Repression of Mcl-1 expression by the CDC7/CDK9 inhibitor PHA-767491 overcomes bone marrow stroma-mediated drug resistance in AML.

O' Reilly, Eimear; Dhami, Sukhraj Pal S; Baev, Denis V; Ortutay, Csaba; Halpin-McCormick, Anna; Morrell, Ruth; Santocanale, Corrado; Samali, Afshin; Quinn, John; O'Dwyer, Michael E; Szegezdi, Eva.

Sci Rep ; 8(1): 15752, 2018 10 25.

Artículo en Inglés | MEDLINE | ID: mdl-30361682

9.

New developments in the treatment of multiple myeloma - clinical utility of daratumumab.

McEllistrim, Cian; Krawczyk, Janusz; O'Dwyer, Michael E.

Biologics ; 11: 31-43, 2017.

Artículo en Inglés | MEDLINE | ID: mdl-28442888

10.

Targeting Selectins and Their Ligands in Cancer.

Natoni, Alessandro; Macauley, Matthew S; O'Dwyer, Michael E.

Front Oncol ; 6: 93, 2016.

Artículo en Inglés | MEDLINE | ID: mdl-27148485

11.

RNA interference for multiple myeloma therapy: targeting signal transduction pathways.

Guo, Jianfeng; McKenna, Sharon L; O'Dwyer, Michael E; Cahill, Mary R; O'Driscoll, Caitriona M.

Expert Opin Ther Targets ; 20(1): 107-21, 2016.

Artículo en Inglés | MEDLINE | ID: mdl-26190583

12.

In vitro studies of the combination of imatinib mesylate (Gleevec) and arsenic trioxide (Trisenox) in chronic myelogenous leukemia.

La Rosée, Paul; Johnson, Kara; O'Dwyer, Michael E; Druker, Brian J.

Exp Hematol ; 30(7): 729-37, 2002 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-12135670

13.

Glycosylation-Based Serum Biomarkers for Cancer Diagnostics and Prognostics.

Kirwan, Alan; Utratna, Marta; O'Dwyer, Michael E; Joshi, Lokesh; Kilcoyne, Michelle.

Biomed Res Int ; 2015: 490531, 2015.

Artículo en Inglés | MEDLINE | ID: mdl-26509158

14.

The cancer glycome: carbohydrates as mediators of metastasis.

Glavey, Siobhan V; Huynh, Daisy; Reagan, Michaela R; Manier, Salomon; Moschetta, Michele; Kawano, Yawara; Roccaro, Aldo M; Ghobrial, Irene M; Joshi, Lokesh; O'Dwyer, Michael E.

Blood Rev ; 29(4): 269-79, 2015 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-25636501

15.

Recent advances in Philadelphia chromosome-positive malignancies: the potential role of arsenic trioxide.

O'Dwyer, Michael E; La Rosée, Paul; Nimmanapalli, Ramedivi; Bhalla, Kapil N; Druker, Brian J.

Semin Hematol ; 39(2 Suppl 1): 18-21, 2002 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-12012318

16.

Clonal evolution in chronic myelogenous leukemia.

Cortes, Jorge; O'Dwyer, Michael E.

Hematol Oncol Clin North Am ; 18(3): 671-84, x, 2004 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-15271399

17.

Nilotinib 300 mg BID as frontline treatment of CML: prospective analysis of the Xpert BCR-ABL monitor system and significance of 3-month molecular response.

O'Dwyer, Michael E; Swords, Ronan; Nagler, Arnon; McMullin, Mary Frances; le Coutre, Philipp D; Langabeer, Stephen E; Alvarez-Iglesias, Alberto; Fan, Hongxin; Woodman, Richard C; Giles, Francis J; Conneally, Eibhlin.

Leuk Res ; 38(3): 310-5, 2014 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-24333114

18.

Chronic myelogenous leukemia.

O'Dwyer, Michael E.

Curr Opin Oncol ; 15(1): 10-5, 2003 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-12490756

19.

How to monitor patients with chronic myelogenous leukemia.

O'Dwyer, Michael E.

J Natl Compr Canc Netw ; 1(4): 513-7, 2003 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-19774742

20.

STI571 as a targeted therapy for CML.

O'Dwyer, Michael E; Mauro, Michael J; Druker, Brian J.

Cancer Invest ; 21(3): 429-38, 2003 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-12901289

Portal de Búsqueda de la BVS

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: